Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.52 |
| ▸ | ACACB | O00763 | 1/20 | 0.50 |
| ▸ | ACACA | Q13085 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 8/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | GUCY1A1 | Q02108 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL561986 | 0.98 | ACLY (0.50) | ACLYACACBACACAPPARATBXAS1 | |
| Hydrochloric Acid SCHEMBL2867978 | 0.98 | ACLY (0.50) | ACLYACACBACACAPPARATBXAS1 | |
| SCHEMBL154712 | 0.93 | ACLY (0.55) | ACLYACACBACACAPPARATBXAS1 | |
| SCHEMBL250911 | 0.91 | ACLY (0.59) | ACLYACACBACACAPPARATBXAS1 | |
| Hydrochloric Acid SCHEMBL621977 | 0.91 | ACLY (0.53) | ACLYACACBACACAPPARATBXAS1 | |
| Hydrochloric Acid SCHEMBL562371 | 0.91 | ACLY (0.53) | ACLYACACBACACAPPARATBXAS1 | |
| Hydrochloric Acid SCHEMBL561963 | 0.89 | ACLY (0.57) | ACLYACACBACACAPPARATBXAS1 | |
| Hydrochloric Acid SCHEMBL1175992 | 0.89 | ACLY (0.57) | ACLYACACBACACAPPARATBXAS1 | |
| SCHEMBL1106837 | 0.88 | ACLY (0.43) | ACLYACACBACACAPPARATBXAS1 | |
| SCHEMBL232206 | 0.85 | KDM4E (0.36) | ACLYACACBACACACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12467088-B2 | Probe-based analysis of nucleic acids and proteins | 10X GENOMICS, INC. (US) | 2025-11-11 | — | — | US | claimed |
| US-20250171845-A1 | PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINS | 10X GENOMICS, INC. | 2025-05-29 | — | — | US | claimed |
| EP-4044956-B1 | COMPOSITE TISSUE MARKERS DETECTABLE VIA MULTIPLE DETECTION MODALITIES | VIEW POINT MEDICAL INC (US) | 2024-04-17 | — | — | EP | claimed |
| US-11703427-B2 | Methods and systems for cell and bead processing | 10X GENOMICS, INC. (US) | 2023-07-18 | — | — | US | claimed |
| EP-4110941-A1 | METHOD FOR ISOLATING NUCLEI AND CELLS FROM TISSUES | 10X Genomics, Inc. (US) | 2023-01-04 | — | — | EP | claimed |
| WO-2021158925-A1 | QUANTITATIVE AND AUTOMATED PERMEABILIZATION PERFORMANCE EVALUATION FOR SPATIAL TRANSCRIPTOMICS | 10X GENOMICS, INC. (US) | 2021-08-12 | — | — | WO | claimed |
| US-20200033237-A1 | METHODS AND SYSTEMS FOR CELL AND BEAD PROCESSING | 10X GENOMICS, INC. | 2020-01-30 | — | — | US | claimed |
| EP-2971064-B1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | VENTANA MED SYST INC (US) | 2019-10-16 | — | — | EP | claimed |
| EP-2931921-B1 | LABEL-FREE METHODS FOR ISOLATION AND ANALYSIS OF NUCLEIC ACIDS ON SOLID PHASE DEVICE | AGENCY SCIENCE TECH & RES (SG) | 2018-10-31 | — | — | EP | claimed |
| EP-2308380-B1 | Wound closure device | COVIDIEN LP (US) | 2018-06-13 | — | — | EP | claimed |
| EP-0559655-B1 | IMIDOESTER CROSS-LINKED HEMOGLOBIN COMPOSITIONS | UPJOHN CO (US) | 1995-03-15 | — | — | EP | claimed |
| EP-0388220-B1 | Compositions for the sustained release of chlorhexidine | YISSUM RES DEV CO (IL) | 1995-03-08 | — | — | EP | claimed |
| EP-0246809-B1 | SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1992-09-30 | — | — | EP | claimed |
| EP-0181033-B1 | CONTROL FOR BLOOD GAS ANALYZERS AND HEMOGLOBIN ANALYSIS | AKZO N.V. (NL) | 1990-02-21 | — | — | EP | claimed |
| EP-0317085-A2 | Processed red blood cells and process for producing the same | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1989-05-24 | — | — | EP | claimed |
| WO-1989003040-A1 | METHOD FOR THE PRODUCTION OF ANTIGENIC PROTEIN-HAPTEN CONJUGATES, AND ANTIBODIES CORRESPONDING THERETO | CAMBRIDGE LIFE SCIENCES PLC (GB) | 1989-04-06 | — | — | WO | claimed |
| EP-0309299-A1 | Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto | CAMBRIDGE LIFE SCIENCES PLC (GB) | 1989-03-29 | — | — | EP | claimed |
| US-4665089-A | IMIDOESTER OR N-HYDROXYSUCCINIMIDE ESTER | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1987-05-12 | — | — | US | claimed |
| EP-0199103-A2 | Process for preventing or reversing cataract formation using protein modification reagents | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1986-10-29 | — | — | EP | claimed |
| EP-0014530-B1 | METHOD FOR DETECTING AND DETERMINING PROTEINACEOUS SPECIFIC BINDING AGENTS AND MATERIALS BINDABLE THERETO, TEST COMPOSITION AND TESTKIT THEREFOR | UNILEVER PLC (GB) | 1984-03-14 | — | — | EP | claimed |